Equities

Formosa Pharmaceuticals Inc

6838:TAI

Formosa Pharmaceuticals Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)39.10
  • Today's Change0.150 / 0.39%
  • Shares traded151.66k
  • 1 Year change-22.57%
  • Beta--
Data delayed at least 20 minutes, as of Nov 25 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,216421209
Total Receivables, Net330.030.02
Total Inventory------
Prepaid expenses393526
Other current assets, total0.440.130.04
Total current assets1,288456234
Property, plant & equipment, net34108.19
Goodwill, net313131
Intangibles, net346380415
Long term investments270--
Note receivable - long term------
Other long term assets0.650.670.65
Total assets1,727878689
LIABILITIES
Accounts payable------
Accrued expenses98567.17
Notes payable/short-term debt000
Current portion long-term debt/capital leases5.502.502.76
Other current liabilities, total154119.37
Total current liabilities2587019
Total long term debt244.410.42
Total debt306.903.18
Deferred income tax4.454.945.43
Minority interest0.540.570.49
Other liabilities, total300332270
Total liabilities587411296
SHAREHOLDERS EQUITY
Common stock1,3411,136988
Additional paid-in capital1,780979620
Retained earnings (accumulated deficit)(1952)(1630)(1202)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(30)(18)(15)
Total equity1,140467393
Total liabilities & shareholders' equity1,727878689
Total common shares outstanding134114103
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.